Lumibird S.A [LBIRD] vs bioMérieux S.A [BIM] Detailed Stock Comparison

Lumibird S.A.

EURONEXT
Loading...

bioMérieux S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Lumibird S.A. wins in 1 metrics, bioMérieux S.A. wins in 16 metrics, with 0 ties. bioMérieux S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lumibird S.A. bioMérieux S.A. Better
P/E Ratio (TTM) 38.59 21.24 bioMérieux S.A.
Price-to-Book Ratio 2.64 2.04 bioMérieux S.A.
Debt-to-Equity Ratio 70.86 11.24 bioMérieux S.A.
PEG Ratio 20.84 N/A N/A
EV/EBITDA 19.44 7.32 bioMérieux S.A.
Profit Margin (TTM) 6.13% 9.77% bioMérieux S.A.
Operating Margin (TTM) 13.36% 16.81% bioMérieux S.A.
EBITDA Margin (TTM) 13.36% 16.81% bioMérieux S.A.
Return on Equity 6.93% 9.54% bioMérieux S.A.
Return on Assets (TTM) 3.73% 7.66% bioMérieux S.A.
Free Cash Flow (TTM) $12.64M $453.10M bioMérieux S.A.
1-Year Return 33.33% -37.04% Lumibird S.A.
Price-to-Sales Ratio (TTM) 2.38 2.06 bioMérieux S.A.
Enterprise Value $630.61M $8.26B bioMérieux S.A.
EV/Revenue Ratio 2.76 2.03 bioMérieux S.A.
Revenue per Share (TTM) $10 $34 bioMérieux S.A.
Earnings per Share (Diluted) $0.64 $3.34 bioMérieux S.A.
Beta (Stock Volatility) 0.87 0.67 bioMérieux S.A.

Lumibird S.A. vs bioMérieux S.A. Stock Performance Analysis

Loading Price Chart...

LBIRD
BIM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lumibird S.A.-0.57%3.35%25.00%29.31%29.31%29.31%
bioMérieux S.A.1.00%-2.50%-0.92%-30.59%-34.91%-35.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lumibird S.A.33.33%33.33%33.33%33.33%33.33%33.33%
bioMérieux S.A.-37.04%-21.51%-18.74%87.61%255.74%255.74%

Performance & Financial Health Analysis: Lumibird S.A. vs bioMérieux S.A.

MetricLBIRDBIM
Market Information
Market Cap i€540.61M€8.37B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i41,440201,885
90 Day Avg. Volume i35,706150,932
Last Close€26.10€70.80
52 Week Range€13.00 - €27.65€68.05 - €128.30
% from 52W High-5.61%-44.82%
All-Time High€27.65 (May 29, 2026)€144.80 (Oct 12, 2020)
% from All-Time High-5.61%-51.10%
Growth Metrics
Quarterly Revenue Growth0.09%-0.03%
Quarterly Earnings Growth0.56%0.09%
Financial Health
Profit Margin (TTM) i0.06%0.10%
Operating Margin (TTM) i0.13%0.17%
Return on Equity (TTM) i0.07%0.10%
Debt to Equity (MRQ) i70.8611.24
Cash & Liquidity
Book Value per Share (MRQ)€9.37€34.77
Cash per Share (MRQ)€2.80€4.83
Operating Cash Flow (TTM) i€29.00M€788.40M
Levered Free Cash Flow (TTM) i€3.60M€615.77M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Lumibird S.A. vs bioMérieux S.A.

MetricLBIRD (Apr 24, 2026)BIM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i38.5921.24
Forward P/E i20.8413.90
PEG Ratio i20.84N/A
Price to Sales (TTM) i2.382.06
Price to Book (MRQ) i2.642.04
Market Capitalization
Market Capitalization i€540.61M€8.37B
Enterprise Value i€630.61M€8.26B
Enterprise Value Metrics
Enterprise to Revenue i2.762.03
Enterprise to EBITDA i19.447.32
Risk & Other Metrics
Beta i0.870.67
Book Value per Share (MRQ) i€9.37€34.77

Financial Statements Comparison: Lumibird S.A. vs bioMérieux S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLBIRD (2025)BIM (2025)
Revenue/Sales i228.53M4.07B
Cost of Goods Sold i82.29M1.76B
COGS % of Revenue i36.0%43.3%
Gross Profit i146.24M2.31B
Gross Margin i64.0%56.7%
Research & Development iN/A507.40M
Operating Income (EBIT) i25.65M694.70M
Operating Margin i11.2%17.1%
EBITDA i46.26M1.03B
EBITDA Margin i20.2%25.4%
Pre-Tax Income i18.95M525.70M
Pre-Tax Income % of Revenue i8.3%12.9%
Income Tax i4.94M128.80M
Income Tax % of Revenue i2.2%3.2%
Net Income (Profit) i14.01M396.90M
Profit Margin i6.1%9.8%

Balance Sheet & Liquidity Metrics

MetricLBIRD (2025)BIM (2025)
Cash & Equivalents i61.57M569.80M
Total Current Assets i216.83M2.54B
Total Current Assets % of Revenue i94.9%62.4%
Total Current Liabilities i87.71M1.06B
Total Current Liabilities % of Revenue i38.4%26.2%
Long-Term Debt i124.41M330.00M
Long-Term Debt % of Revenue i54.4%8.1%
Total Shareholders Equity i206.31M4.11B
Retained Earnings i113.55M397.50M
Retained Earnings % of Revenue i49.7%9.8%
Property, Plant & Equipment i11.81M1.83B

Cash Flow Statement Comparison

MetricLBIRD (2025)BIM (2025)
Operating Cash Flow i19.79M364.10M
Operating Cash Flow % of Revenue i8.7%8.9%
Capital Expenditures i-16.10M-324.90M
Free Cash Flow i12.64M453.10M
FCF Margin i5.5%11.1%
Debt Repayment i-28.64M-63.20M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLBIRDBIM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i22.03M117.99M
Float Shares i10.38M44.62M
% Held by Insiders i53.58%66.46%
% Held by Institutions i17.65%18.16%
% Held by Public i28.77%15.38%

Dividend Analysis & Yield Comparison: Lumibird S.A. vs bioMérieux S.A.

MetricLBIRDBIM
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A